Medication Assisted Treatment for Opioid Use Disorder - The Therapists's Role

Register

Topics

1. Overview of FDA-approved for opioid use disorder (MOUD)
2. Research supporting each of the medications
3. Addressing stigma and misconceptions about MOUD
4. Supporting clients in medication adherence and recovery

Learning Objectives

• By the end of the session, participants will be able to accurately describe the differences between buprenorphine, methadone, and naltrexone treatments for opioid use disorder.
• Participants will be able to identify at least one client characteristic that would make them a potential candidate for each medication.
• Participants will be able to explain why medication assisted treatment with methadone or buprenorphine is not just addiction to another substance (i.e. contrary to this stigma).